{"id":"W4327684313","doi":"10.1080/13696998.2023.2192588","title":"Health utilities and quality-adjusted life years for patients with amyotrophic lateral sclerosis receiving <i>reldesemtiv</i> or placebo in FORTITUDE-ALS","year":2023,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"Cytokinetics","keywords":"Medicine; Placebo; Amyotrophic lateral sclerosis; Post-hoc analysis; Quality of life (healthcare); Confidence interval; Quality-adjusted life year; Post hoc; Physical therapy; Randomized controlled trial; Clinical trial; Internal medicine; Cost effectiveness; Disease; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003139115,0.0001660407,0.0008727681,0.0003288524,0.00006882108,0.00005718736,0.000214743,0.0001899647,0.0001176498],"category_scores_gemma":[0.002301287,0.0001154583,0.0001038657,0.0002369188,0.0001785121,0.0002640249,0.0001151452,0.0005770068,0.000005782822],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003246524,"about_ca_system_score_gemma":0.001149601,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002194912,"about_ca_topic_score_gemma":0.0003864129,"domain_scores_codex":[0.9972585,0.0001626747,0.001160148,0.0002463536,0.0006458042,0.000526479],"domain_scores_gemma":[0.9975193,0.0009073956,0.0004416958,0.0001718222,0.0001502384,0.0008095579],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02084573,0.0007439229,0.8901842,0.001548134,0.0006966969,0.00009201716,0.002723721,0.0002362652,0.00005272591,0.0002828646,0.006207364,0.07638631],"study_design_scores_gemma":[0.01133959,0.002141756,0.9821706,0.001794672,0.00002480343,0.00002044886,0.000248836,0.001277114,0.000004615648,0.00008077198,0.0007582728,0.0001385148],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.980442,0.0002045293,0.00003552295,0.01852334,0.0001807014,0.0005627343,0.00002107542,0.00002012465,0.000009957209],"genre_scores_gemma":[0.991033,0.006229967,0.0006322581,0.001647184,0.0002557295,0.00002185009,0.00001272372,0.00004070749,0.0001266441],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09198636,"threshold_uncertainty_score":0.4708251,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.101716665152335,"score_gpt":0.3496601982696639,"score_spread":0.2479435331173289,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}